Lv1
90 积分 2026-02-28 加入
Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer by Inhibiting c-MYC–mediated Tumorigenesis
17小时前
待确认
Type II JAK2 Inhibitor Gets Off to a Strong Start
1个月前
已完结
Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors
1个月前
已完结
Adopting GPR75 in treating obesity: unraveling the knowns and unknowns of this orphan GPCR
4个月前
已完结
TXNRD1 drives the innate immune response in senescent cells with implications for age-associated inflammation
5个月前
已完结
DUSP1 Specific Protac Selectively Targets the JAK2 V617F Expressing Cells
5个月前
已关闭
FH-2001 is a novel FGFR/VEGFR dual inhibitor with immune-modulating activity
7个月前
已完结
皖公网安备34019202002308
